These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 6723935

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Heterogeneity of type III procollagen N-terminal peptides in BAL fluid from normal and fibrotic lungs.
    Harrison NK, McAnulty RJ, Kimpton WG, Fraser JR, Laurent TC, Laurent GJ.
    Eur Respir J; 1993 Nov; 6(10):1443-8. PubMed ID: 8112436
    [Abstract] [Full Text] [Related]

  • 4. Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance.
    Chesnutt AN, Matthay MA, Tibayan FA, Clark JG.
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):840-5. PubMed ID: 9310002
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis.
    Bjermer L, Lundgren R, Hällgren R.
    Thorax; 1989 Feb; 44(2):126-31. PubMed ID: 2928996
    [Abstract] [Full Text] [Related]

  • 8. Histometric changes in connective fibers of the lung following paraquat administration in rats.
    Shirai M, Fujise H, Masaoka T, Takeda S, Tsuboi T, Akahori F.
    J Toxicol Sci; 1993 Aug; 18(3):167-70. PubMed ID: 8246308
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of mesenchymal stromal cells' chemotactic effect to ameliorate paraquat-induced pulmonary fibrosis.
    Zhang H, Xiao B, Jiang L, Yao W, Shen H, Xiang X.
    Toxicol Lett; 2019 Jun 01; 307():1-10. PubMed ID: 30658152
    [Abstract] [Full Text] [Related]

  • 13. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression.
    Liu MW, Su MX, Tang DY, Hao L, Xun XH, Huang YQ.
    BMC Pulm Med; 2019 Feb 11; 19(1):35. PubMed ID: 30744607
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protective effect of ambroxol against paraquat-induced pulmonary fibrosis in rats.
    Zhi QM, Yang LT, Sun HC.
    Intern Med; 2011 Feb 11; 50(18):1879-87. PubMed ID: 21921364
    [Abstract] [Full Text] [Related]

  • 17. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
    Xie H, Lu J, Zhu Y, Meng X, Wang R.
    Toxicol Lett; 2018 Oct 01; 295():408-415. PubMed ID: 30036685
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.